down arrow

Sanofi Consumer

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE0UOS01011
  • NSEID: SANOFICONR
  • BSEID: 544250
INR
4,932.45
54.45 (1.12%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 5.86 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Sanofi Consumer Healthcare India Ltd stock-summary
stock-summary
Sanofi Consumer Healthcare India Ltd
Mid Cap
Pharmaceuticals & Drugs
Sanofi Consumer Healthcare India Limited was incorporated on May 10, 2023, pursuant to a Certificate of Incorporation, issued by the Registrar of Companies, Central Registration Centre. Pursuant to the Scheme becoming effective, the Consumer Healthcare Division (CHC) business of Sanofi India Limited (SIL) got demerged into the Company as a going concern through the Scheme of Arrangement and became effective from June 1, 2024.
Company Coordinates stock-summary
Icon
No Company Details Available
stock-summary Capital Structure
Capital Structure stock-summary
Present Equity Capital
INR 23.03 Cr
Number of Shares
2.3 Cr
Face Value
INR 10.0
Date
Number
of Shares(Cr)
Equity
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
17-Jun-2024
2.3
23.03
23030622
10
Scheme of arrangement - Demerger
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 12 Schemes (14.78%)

FIIs

Held by 97 FIIs (4.42%)

Promoter with highest holding

Opella Healthcare Participations B.v. (60.4%)

Highest Public shareholder

Life Insurance Corporation Of India (5.67%)

Individual Investors Holdings

7.01%

stock-summary Board of Directors
stock-summary
stock-summary
Management
Designation
Remuneration
stock-recommendationRaw Materials
Raw Materials Dashboard stock-summary
Raw Materials
Amount(Rs Cr)
% of RM Cost
 
Icon
No Data Available
stock-recommendation Finished Goods
Finished Goods Dashboard stock-summary
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
 
Icon
No Data Available
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
171 Cr
(Quarterly Results - Dec 2024)
Net Profit:
44 Cr
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 11,360 Cr (Mid Cap)

stock-summary
P/E

56.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.94

stock-summary
Return on Equity

11,872.25%

stock-summary
Price to Book

6,608.43